Europe Blood Purification Equipment Market 2021-2031

Blood Purification is a therapy that is based on the extracorporeal treatment of blood. The therapy works by removal of toxins and pathogenic agents from the blood via bioseparation, including dialysis, filtration, adsorption or a combination of them. It allows the withdrawal of blood from the body into the equipment or device for removing impurities and pumps it back into the body. Blood purification therapy is also used for the treatment of various disorders which are refractory to conventional therapies, for instance, drug administration and surgeryEurope blood purification equipment market was valued at $2,138.3 million in 2021 and will grow by 4.9% annually over 2021-2031 owing to the increasing prevalence of blood-related diseases, rising geriatric population, technological innovations, growing healthcare expenditure, rising adoption of home based healthcare, and the rising health consciousness amid COVID-19 pandemic. Some of the factors that are anticipated to drive the growth of blood purification equipment include an increase in immune and metabolic disorders, such as kidney failures, a rise in cases of hypertension and diabetes, and an increase in the number of elderly people worldwide who are more susceptible to kidney-related disorders. In the upcoming years, the market is anticipated to rise due to rising breakthroughs in pathophysiology, haematology, and blood purifying techniques. The high equipment costs & dangers related to blood purifying techniques, however, are anticipated to restrain the expansion of the global market for blood purification equipment. Haemodialysis therapy is currently one of the most widely used applications of the blood purification technique. The development of cutting-edge tools and systems for blood purification for hemodialysis patients is being driven by a large population base that suffers from renal failures. Additionally, because top market players are investing heavily in the R&D of these systems, the market is anticipated to grow to include several potential growth prospects. Additionally, advances in medicine have greatly expanded the use of blood purification in the fields of haematology and pathophysiology of illnesses. This ultimately increased the need for blood purifying devices in recent years, and it is anticipated that this trend will continue during the projected period. Technological developments in blood purification machines will impact the market growth positively during the forecast period. Leading market players plan to launch innovative & advanced blood purification equipment. For example, companies like Jafron and NxStage have created various blood purification devices that have decreased the mortality rate in patients experiencing chronic kidney failure. Newly approved blood purification machines are highly sensitive & allow exhaustive observation. Moreover, this sophisticated blood purification equipment is economical & portable. Therefore, the above-mentioned aspects would bolster the growth of the market in the next few years. On the other hand, there are several processes involved in cleaning blood purifying equipment. Additionally, there are a number of intricate medical equipment with interconnected elements that might be difficult to clean, such as infusion pumps, dialysis machines, etc. People not adequately trained for this operation could be unable to clean it, which would increase the danger of spreading infection, which is one of the most crucial aspect concerning these types of devices. And one of the factor affecting the growth of the market. 

Impact of COVID-19 
The Blood Purification Devices market observed a period of slow growth due to the outbreak of COVID-19, because of the transport-trade restrictions and lockdown of the entire geographies, unavailability of blood purification components and consumables for proper functioning and the closing of major company operations. Several countries were affected due to the pandemic. All other procedures including elective surgeries were stopped temporarily giving major priority to the patient burden due to Covid-19. However, the companies are eventually resuming operations and dealing with the situation post-Covid-19, which was earlier restricted due to containment measures, social distancing, remote working and closing of commercial activities.

Highlighted with 32 tables and 44 figures, this 102-page report “Europe Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange Device), Portability (Portable, Stationary), Indication (Renal Diseases, Sepsis, Others), End User (Hospitals and Clinics, Dialysis Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe blood purification equipment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. 

In-depth qualitative analyses include identification and investigation of the following aspects:
   • Market Structure 
   • Growth Drivers 
   • Restraints and Challenges
   • Emerging Product Trends & Market Opportunities
   • Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe blood purification equipment market in every aspect of the classification from perspectives of Product, Portability, Indication, End User, and Country. 

By Product Type 
     • Hemodialysis Device
     • Blood Filtration Device
     • CRRT Device
     • Hemoperfusion Device
     • Plasma Exchange Device
     • Other Products

By Portability
     • Portable Equipment
     • Stationary Equipment

By Indication
     • Renal Diseases
     • Sepsis
     • Other Indications

By End User
     • Hospitals and Clinics
     • Dialysis Centers
     • Other End Users

By Geography
     • Germany
     • UK
     • France
     • Spain
     • Italy
     • Russia
     • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of the regional market by country and split of key national markets by Portability, Indication, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:  Aethlon Medical, Inc., Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Cerus Corporation, CytoSorbents Corporation, Fresenius SE and Co. KGaA, Healthwell Medical Tech. Co., Ltd., Infomed SA, Jafron Biomedical Co., Ltd., Kaneka Corporation, Nikkiso Co., Ltd., Spectral Medical Inc., SWS Medical Group

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)